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Abstract  
Objectives: To systematically review the evidence for interventions addressing key domains of the 
American Cancer Society (ACS) and American Society of Clinical Oncology (ASCO) Prostate 
Cancer Survivorship Care Guidelines: health promotion, surveillance, physical side effects, 
psychosocial management, and care-coordination.  
Methods: We conducted a systematic review of systematic reviews and meta-analyses of 
interventions targeting ACS/ASCO guideline domains. All titles and abstracts were independently 
assessed for inclusion based on predetermined criteria. Relevant data were extracted and 
assessment of methodological quality performed. 
Results: Forty-four systematic reviews of interventions targeting ACS prostate cancer guideline 
domains were included for review. Exercise and psychosocial interventions were effective for 
improving men’s survivorship outcomes in the domains of health promotion, physical side effects, 
and psychosocial management. Across the domains evidence quality varied and there was a limited 
diversity of participants. No reviews of interventions addressing surveillance and cancer care 
coordination were identified.  
Conclusions: There are substantive knowledge gaps in prostate cancer survivorship research that 
are a barrier to real improvements in men’s outcomes across the breadth of the survivorship 
experience. A targeted research and implementation agenda in prostate cancer survivorship is 
urgently needed if we are to meet the current and future burden of this disease on individuals, 
families, and communities. 
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Prostate cancer is the most commonly diagnosed cancer among men in developed 
countries, with over 1.1 million men diagnosed each year worldwide 1. Advances in treatment 
have led to significant increases in survival rates, with over 90% of men diagnosed with prostate 
cancer living at least five or more years 2, 3. Although advances in treatment mean that men are 
surviving longer, they may not be surviving well. A substantive group of men with prostate 
cancer experience heightened psychological distress 4 and unmet needs in psychological and 
sexual supportive care are common 5, 6. Disease and treatment side effects include fatigue 7, 
erectile dysfunction, and incontinence 8, sarcopenia 9, and increased risk of cardiometabolic 
disease 10, with these patient populations characterised by a high prevalence of 
overweight/obesity and insufficient physical activity that may contribute to poorer quality of life 
11. Men with prostate cancer also have an increased risk of suicide that is especially evident in 
the first twelve months after diagnosis and in men with advanced disease 12, 13. Thus, addressing 
the unique and long term needs of prostate cancer survivors is critical to quality oncology care. 
The importance of survivorship care was first formally recognised by the Institute of 
Medicine in 2005 14. In 2014 the American Cancer Society (ACS) published specific Prostate 
Cancer Survivorship Care Guidelines, which were subsequently endorsed by the American 
Society of Clinical Oncology (ASCO) 15, 16. These guidelines aim to promote comprehensive 
follow-up care, optimal health, and quality of life for men with prostate cancer with five key 
domains for action: health promotion; surveillance for prostate cancer recurrence and screening 
for second primary cancers; management of longterm physical side effects; psychosocial 
management; and care coordination. The guidelines recommend survivors maintain a healthy 
weight by limiting high-calorific foods; engage in regular physical activity including weight-
bearing exercises; consume a diet high in fruits, vegetables, and whole grains; avoid or limit 
alcohol consumption; and avoid smoking tobacco. In order to monitor for prostate cancer 
recurrence, it is recommended that Prostate Specific Antigen (PSA) levels are assessed every 6 
to 12 months for the first five years after treatment, and a digital rectal examination is performed 
annually 17. As prostate cancer survivors may be at increased risk of bladder or colorectal 
cancers, survivors need to be monitored and symptoms referred for thorough evaluation to detect 
any second primary cancers early 18. The guidelines highlight the importance of assessing and 
managing long-term side-effects such as anaemia, bowel dysfunction, sexual dysfunction, and 
cardiometabolic risks, tailored for the type of cancer treatment received 15, 16. Additionally, 
survivors should be routinely screened using the Distress Thermometer 19 at various stages of the 
cancer pathway, with patientreported quality of life recorded at diagnosis and annually 
thereafter as part of survivorship care 20. In order to improve care-coordination, it is advised that 
cancer specialists provide all prostate cancer survivors with a survivorship care plan, 
incorporating both treatment summaries and clinical follow-up recommendations for primary 
care practitioners 15, 16.  
The ACS survivorship care domains and corresponding guidelines were developed using a 
combination of expert consensus and an evidence synthesis which was largely observational, 
based on small sample sizes, and with great variability in methodologies 15. In addition, 
according to the ACS process, these guidelines need to be revised every 5 years 15. Thus, it is 
timely to investigate the evidence presented in systematic reviews that relate to prostate cancer 
survivorship care. Specifically, there is a need to synthesise the evidence regarding the overall 
effectiveness of various intervention types, identify conflicting evidence, and determine whether 
this can sufficiently inform improved guidelines for targeting care across the survivorship 
domains for men with prostate cancer. Accordingly, we undertook a systematic review of the 
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evidence for interventions addressing key domains of the American Cancer Society (ACS) and 
American Society of Clinical Oncology (ASCO) Prostate Cancer Survivorship Care Guidelines: 
health promotion, surveillance, physical side effects, psychosocial management, and care-
coordination. Key objectives were to identify systematic reviews about interventions that map to 
these survivorship domains and evaluate the extent of evidence available to support specific 
approaches.  
Methods 
Systematic reviewing methods were used to identify existing reviews rather than original 
research. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) checklist to guide the conduct and reporting of this review 21. 
Search strategy 
Electronic searches were conducted in the Cochrane Database of Systematic Reviews, the 
Database of Abstracts and Reviews of Effects, CINAHL, Scopus, PsycInfo, and PubMed, using 
the search strategies in Appendix A. Key terms related to “prostate cancer”; AND “intervention” 
OR “RCT” or “trial” or “program”; AND “survivorship” OR “quality of life” OR “side effects” 
OR “surveillance” OR “healthy lifestyle” OR “care-coordination”; AND “review”. Searches 
were conducted from inception to 27th July 2018, and limited to English language. The search 
was not date limited. After duplicates were removed, two authors independently screened the 
title and abstract of each citation and then retrieved potentially eligible articles for full text 
review. Any queries were resolved through discussion with the wider research team. Inter-rater 
agreement on eligible articles was calculated, with Cohen’s κ of 0.83 indicating near perfect 
agreement between authors (FCW, NR). Additional hand searching of reference lists of included 
studies was also conducted.  
Eligibility criteria 
Systematic reviews or meta-analyses examining trial studies which assessed the 
effectiveness of an intervention in comparison to control conditions on any outcome within a 
prostate cancer survivorship domain were eligible for inclusion. All titles and abstracts were 
independently screened, and relevant reviews were retrieved and assessed for inclusion. Any 
disagreement within this process was resolved through discussion within the team. Inclusion 
criteria were organised in accordance with the patient, intervention, comparison, outcome 
(PICO) reporting structure 21. Review articles were included if they focused on populations of 
adult prostate cancer survivors, or where a subset of included studies investigated adult men with 
prostate cancer; evaluated controlled or uncontrolled trials of interventions for prostate cancer 
survivors; and focused on survivorship outcomes within the five domains. We excluded reviews 
that reported on general cancer populations or trials of mixed cancer groups, interventions that 
were conducted pre-diagnosis, and studies focusing on clinical or medical anti-cancer treatment 
only.  
Data extraction and analysis 
From each eligible systematic review or meta-analysis, data was extracted relating to 
authors, year, objectives, participants, intervention types, outcome variables, quality assessment, 
and authors’ conclusions. The reviews varied in whether they grouped studies according to 
intervention types (e.g. exercise interventions to improve a range of outcomes), outcomes (e.g. 
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any intervention to improve quality of life), or both (e.g. exercise interventions to improve 
quality of life). Findings were summarised according to the survivorship domain that was the 
outcome of interest within each review article.  Reviews which addressed outcomes within more 
than one survivorship domain were therefore summarised in more than one category. From this, 
a narrative synthesis of the conclusions of reviews published within the last five years (since the 
guidelines release) about intervention effectiveness was undertaken. Additionally, a summary 
table was created to describe the quantity and quality of the evidence across each of the domains. 
No statistical analyses or meta-analyses were conducted. Appraisal of individual component 
studies was beyond the scope of this synthesis, as these were the aims of the original systematic 
reviews and meta-analyses. 
Quality Assessment 
Each systematic review was critically appraised using a modified checklist from the 
Database of Abstracts of Reviews of Effects (DARE). The checklist was used to assess the 
reliability and validity of included review articles 22. To be included in the current synthesis, 
reviews had to meet at least five of the seven criteria provided in Figure 1. In order to assess the 
quality of the overall body of evidence within each domain, we relied on review authors’ 
conclusions regarding the quality of interventions within each review. These are summarized 
within the presentation of results.  
Results 
Overall, the search identified 902 articles. After removal of duplicates and title and 
abstract screening, 63 articles were examined in greater detail. Of these, 46 unique systematic 
reviews met the inclusion criteria, however 2 were excluded after quality assessment, leaving 44 
review articles in the current synthesis (Figure 2). Overall the included review articles reported 
on a total of 548 studies; however, this included only 212 unique studies as there was significant 
overlap between review articles in the same domains. The reviews varied considerably in 
inclusion criteria and objectives. The majority of reviews were of high methodological quality, 
meeting all seven criteria on the DARE checklist (n=27, 61%). The most common issues 
reducing review quality were not involving more than one author in each stage of the review 
process, and not assessing the quality of the primary studies. Appendix B presents the main 
characteristics of each included review.  
Coverage of domains 
Overall, the majority of systematic reviews reported on outcomes relating to psychosocial 
management (n = 23), health promotion (n = 19) and physical side effects (n = 17). No reviews 
investigated care-coordination as a primary outcome, however, three review articles reported on 
interventions targeting individual’s self-efficacy, uncertainty, and knowledge regarding care 
which could be considered a proxy for care-coordination. No articles were located that 
systematically reviewed interventions designed to improve surveillance for recurrent cancer or 
screening for other primary cancers. Eleven of the included reviews (25%) conducted a meta-
analysis for some or all of the primary studies, while for the majority of reviews this was not 
possible due to considerable heterogeneity across studies.  
Participant characteristics 
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The majority of included reviews focused on a broad population of men diagnosed with 
prostate cancer, including men with any stage of cancer, and undergoing any treatment type. 
Two reviews excluded men with advanced stage of disease due to the different treatment and 
outcome pathways 23, 24. Additionally, eight of the included reviews focused only on men 
undergoing androgen deprivation therapy (ADT) 25-32, while three focused only on those 
undergoing radical prostatectomy 33-35, undertaking an evaluation of the effect of exercise 
interventions on differing treatment-related side effects and adverse events. For the reviews 
investigating interventions to assist men undergoing ADT, seven reviews focused on body 
composition, weight gain, and cardiometabolic risk outcomes, while one review focused on 
depression, anxiety, and quality of life 25. For men undergoing radical prostatectomy, the reviews 
focused on physical symptoms known to cause common side effects including erectile 
dysfunction and incontinence. Further regarding the populations of interest in the current 
reviews, only one review focused on ethnic minority populations in America 36, while one other 
review included three studies addressing ethnicity as a mediator 37.  
Intervention characteristics 
 The included reviews reported on a range of individual intervention types, classified 
primarily into exercise, nutrition, psychosexual or psychosocial approaches. Exercise 
interventions consisted of aerobic training, resistance training, flexibility exercise, unsupervised 
physical activity, pelvic floor or sphincter training, and qigong. Nutrition interventions included 
structured diet regimes (such as low-fat, high-fibre) or dietary modification, dietary counselling, 
individual supplements, or any combination. Psychosocial interventions were defined as 
interventions involving one of the following components: psychosexual, education, cognitive
behavioural, relaxation, supportive counselling, peer support, and communication, and were 
often multi-modal. 
Narrative synthesis 
To address the second research question regarding the effectiveness of interventions in 
addressing singular domains of survivorship, the combined findings and conclusions of review 
articles published within the last five years are summarized in a narrative synthesis. Twenty-
eight of the review articles (63%) were published after 2013, with the overall conclusions from 
the body of evidence presented in Table 1. Nine review articles assessed the effectiveness of 
exercise interventions on a range of outcomes across multiple domains of survivorship, thus 
these reviews are included in the synthesis more than once.  
Health promotion 
Eleven review articles focused on health promotion outcomes, investigating the impact of 
nutrition and exercise interventions on body weight, body composition, physical activity levels, 
and PSA levels. Reviews in this domain of survivorship reported on nutrition (n=4), exercise 
(n=10), or combination (n=3) interventions which included aerobic and/or resistance training, 
diet, and dietary supplements. No review reported on individual studies which investigated 
outcomes related to smoking, or alcohol consumption. Reviews investigating evidence relating to 
exercise interventions generally reported higher quality bodies of evidence than reviews of 
combination or nutrition interventions. Overall, the reviews included in the health promotion 
domain suggest that there is strong, high-quality evidence of the effectiveness of exercise 
interventions, with inconclusive evidence for nutrition interventions.  
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Five reviews reported that exercise interventions, such as aerobic and resistance training, 
could be effective in improving physical activity levels 27, 28, 30, 38, 39. One review of diet and 
exercise interventions reported reductions in body weight 40, with diet having more effect on 
weight loss than exercise alone. One review reported the efficacy of exercise interventions to 
preserve and improve lean body mass particularly in the setting of ADT 27, while another review 
reported no effect in other parameters of body composition 31. There was some evidence that 
particular diets and supplements can impact prostate cancer progression. Nutrition interventions 
which were reported to stabilise or decrease serum PSA levels tended to be low in fat, and 
include plant-based supplements (pomegranate, flaxseed, lycopene, and soy) 41, 42; however, soy 
supplementation did not improve any outcomes in one review 31. The overall impact of nutrition 
interventions on PSA levels could not be reliably estimated due to limited, and low-quality trials. 
Surveillance 
No review articles were retrieved which reported on interventions to improve rates of 
surveillance for second primary cancers and monitoring for recurrence.  
Physical side effects 
Sixteen systematic review articles reported on interventions aiming to alleviate ongoing 
physical side effects of prostate cancer treatment in the survivorship period, including fatigue, 
muscle strength, peak oxygen intake, bone health, cardiovascular fitness, sexual function, and 
incontinence. Reviews in this domain of survivorship reported on exercise (n=12), exercise 
combined with diet (n=1), and other complex intervention types (n = 3). Overall, the body of 
evidence addressing the physical side effects of prostate cancer with exercise interventions was 
reported to be high quality.  
Five reviews suggested that a combination of aerobic and resistance training delivered 
during or after treatment for prostate cancer survivors could be effective in improving 
cardiorespiratory fitness, and peak oxygen capacity, with resistance training demonstrating 
improvements to muscular strength 27-29, 32, 43. Exercise interventions were less effective in 
improving other markers of cardiovascular health such as lipid profile, blood pressure, glucose 
and cardiometabolic risk among men undergoing ADT 27, 28, 31, 32. Very few appropriately 
designed studies included long-term duration (e.g. 12 months duration) and implementation of 
osteogenic specific exercise programs (e.g. impact loading) on outcomes of bone health and as a 
result, limited information exists on the effects of exercise on bone mineral density. Evidence 
from seven reviews reported that exercise interventions including aerobic or resistance training, 
qigong, or exercise in combination with healthy diet, may significantly reduce symptoms of 
fatigue 27, 28, 30, 44-47, while one review did not have sufficient data for analysis 29. One review also 
investigated the effectiveness of psychosocial interventions, such as cognitive-behavioural 
therapy and education, and indicated that these may have positive effects on cancer-related 
fatigue 45. For incontinence outcomes, one review reported that preoperative pelvic floor training 
did not improve the time to incontinence above and beyond the benefits of pelvic floor exercise 
post-operatively 33, while another reported that pre-operative pelvic floor exercise improves early 
continence but not long-term continence rates in men after radical prostatectomy 35. One review 
reported that pelvic floor interventions showed significant improvements on urinary symptoms 
both with and without biofeedback, with only three trials examining the effects on sexual 
function and self-esteem 48. One review reported improvements in sexual bother, sexual 
confidence, and sexual satisfaction from interventions utilising psycho-educational, peer support, 
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and cognitive-behavioural group interventions 49. Exercise interventions were reported to have a 
borderline positive effect on sexual activity but no effect on sexual function 50. 
Psychosocial management 
Eighteen included systematic reviews reported on interventions which aimed to improve 
the psychosocial effects of cancer and treatment for prostate cancer survivors, predominantly 
focusing on quality of life, depression, anxiety, and mental health outcomes. Reviews in this 
domain of survivorship reported on the effectiveness of psychosocial (n=5), exercise (n=9), or 
nutrition (n=3) interventions.  
Five reviews reported on the effectiveness of psychosocial interventions on outcomes 
including quality of life, depression, anxiety, and distress 23, 49, 51-53. Reviews with a narrower 
scope reported no significant effect of supportive care interventions on quality of life or 
depression outcomes 23, 51. Two reviews which focused only on depression or anxiety reported 
that psychosocial strategies have a short-term benefit, particularly peer support and 
psychotherapy rather than education, but this was not sustained over time 52, 53. One review 
reported small improvements in some aspects of health-related quality of life, however it was 
uncertain whether these were clinically important improvements as the evidence base was of low 
quality 51. Finally, one comprehensive review with a broader scope included 56 RCTs, and 
reported that combinations of cognitive behavioural, health professional communication, 
psychoeducation, and peer support interventions were most commonly applied and effective in 
improving decision-related distress, mental health, and health-related quality of life outcomes 49.  
Evidence from eight reviews suggested that aerobic and resistance exercise interventions 
show some benefit in improving health-related quality of life outcomes, both during and after 
treatment, particularly with supervised interventions 28, 30, 31, 44, 46, 50, 54, 55. Other reviews reported 
an unclear impact of exercise on quality of life 47, or insufficient data for analysis 27, 29, 33. The 
effect of healthy eating on quality of life was also inconclusive as reported in one review 31. 
Exercise interventions were reported to have no impact on depression or anxiety outcomes 46, or 
again there was insufficient data available 25.  
Care-coordination 
No reviews investigated interventions that target care-coordination.  Two supportive and 
psychosocial care reviews published in the last five years described interventions to improve 
self-efficacy and coping which may be a proxy for care-coordination 23, 51. These reviews found 
little evidence for effectiveness in improving self-efficacy or coping in men with prostate cancer.  
Nevertheless, no reviews were identified in this study that examined professional or system-led 
interventions to improve care coordination for prostate cancer survivorship. 
Discussion 
Current evidence supports the effectiveness of exercise and psychosocial interventions 
for improving men’s prostate cancer survivorship outcomes in the domains of health promotion, 
physical side effects, and psychosocial management. However, evidence quality is varied and 
inconsistent/absent or poor for specific topics within these domains such as diet, sexual well-
being, reduction of alcohol and tobacco consumption. No evidence was found for effective 
approaches to surveillance and care-coordination.  Few studies addressed the needs of high need 
and vulnerable patients; or considered population-based implementation. It is clear that there are 
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significant knowledge gaps in prostate cancer survivorship that will be a barrier to real 
improvements in men’s outcomes across the breadth of the survivorship agenda.  
Exercise interventions are effective at improving cardiorespiratory fitness, muscular 
strength, fatigue, incontinence, physical activity levels and quality of life in men diagnosed with 
prostate cancer, with some evidence on preserving/improving lean mass but with inconsistent 
reports on other parameters of body composition. There is inconclusive evidence for nutrition 
interventions slowing progression of disease, although dietary changes can assist with weight 
loss. Psychosocial interventions incorporating peer support, cognitive-behavioural therapy, and 
tailored supportive care elements are effective in improving quality of life and mental health, 
reducing depression and anxiety and decision-related distress. However, there are differences in 
results across reviews that likely relate to the review approach and currency as well as the need 
for interventions to respond to differences in men’s clinical context, background, 
sociodemographic and cultural circumstances, and personal resources.  
The lack of systematic reviews investigating monitoring for prostate cancer recurrence, 
and surveillance of other primary cancer types may be due to an absence of interventional 
research examining this within survivorship. Several reviews have focused on interventions 
which aim to increase the uptake of PSA testing to screen for prostate cancer, and assess the 
effect on incidence and diagnosis rates 56-59; but limited studies have investigated interventions 
designed to target PSA testing after diagnosis. Follow-up testing and ongoing surveillance is an 
important aspect of survivorship care, helping to detect recurrence and monitor for diagnosis of 
other primary cancers, and is of particular importance for patients undergoing active surveillance 
15. The monitoring guidelines in the ACS/ASCO framework are based on expert consensus, and 
while experts agree that routine monitoring is necessary, the exact intervals and 
recommendations for surveillance varies depending on clinical and treatment factors, and 
continue to evolve 60. Research from America, Australia, and Europe has reported that many men 
undergoing active surveillance may not be adhering to the recommended surveillance protocols, 
with between 13 and 30% of patients not adhering to PSA and biopsy testing guidelines in the 
first 2 years post-diagnosis 61-63. Evidence suggests that exercise interventions can delay the 
transition to active therapy in men undergoing active surveillance, and current randomised 
controlled trials underway to investigate further 64, 65. Until data is routinely collected and 
reported on individuals’ adherence to routine monitoring and surveillance guidelines, for those 
undergoing active surveillance, ADT and other treatments, it cannot be determined whether other 
interventions are necessary. Thus, this remains a neglected survivorship domain in the literature 
which requires further attention.  
There was no review evidence relating to the care-coordination domain of survivorship. 
The ACS guidelines recommend that all patients are given a survivorship care plan by the 
treating specialist, and that specialists and primary care providers discuss the care plan 
components and are involved in shared care 15. However, care plans are not routinely provided to 
patients 66, 67, and the extent to which prostate cancer patients in particular are receiving care 
plans remains unclear. Interventions to overcome barriers to the use of survivorship care plans, 
and encourage shared care between oncology specialists and primary care providers need to be 
identified. There is evidence to suggest that patient navigation and nurse-led interventions may 
be effective in coordinating care during early diagnosis and treatment phases of breast, thyroid, 
and gastro-intestinal cancer 68-71, but trials among men with prostate cancer post-diagnosis have 
not yet been conducted. Future research is needed to examine the extent to which nurse 
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navigation interventions may be effective in assisting with survivorship care planning, or care-
coordination, for men with prostate cancer. 
In terms of assessing the effectiveness of interventions for specific patient groups, 
evidence was again limited. Only one included review, published in 2012, focused on minority 
ethnic populations 36. Prostate cancer survivors with lower income, less education and from non-
white populations have poorer quality of life and a lower likelihood of survival compared with 
higher-income, more educated, and white prostate cancer survivors 72, 73. Yet, there is a lack of 
targeted interventions to address survivorship outcomes for men of minority ethnic backgrounds, 
those living in rural areas, and gay and bisexual men diagnosed with prostate cancer as much of 
the published research is based on the experience of welleducated, heterosexual, white men 73, 
74. Additionally, there was a lack of focus in the included reviews on addressing survivorship 
care interventions for men undergoing treatments other than radical prostatectomy or androgen 
deprivation therapy. Few studies addressed the needs of men with advanced prostate cancer, 
despite the fact that men with advanced disease are known to experience high distress 75. 
Broadening the focus, and developing appropriate interventions targeting a variety of patient 
groups is essential to promote equity in survivorship care. Health policy makers and health 
service providers need to work with researchers to ensure that appropriate survivorship care can 
be delivered to all men with prostate cancer, regardless of individual characteristics or 
circumstances.  
The current ACS guidelines in the domain of health promotion are broad and non-
specific, recommending that prostate cancer survivors engage in at least 150 minutes of physical 
activity each week and eat a diet high in fruits, vegetables, and whole grains 15. For nutrition 
interventions, evidence relating to particular diets and supplements is still inconclusive, and no 
recommendations can be made regarding the use of any nutritional intervention for managing 
PSA levels until further high-quality trials are conducted. From the current review there is high-
quality evidence to suggest that targeted exercise-based interventions have a positive effect on 
physical activity, muscle strength, quality of life, urinary incontinence, and fatigue. While 
exercise interventions may show improvements in outcomes across the domains of health 
promotion, physical side effects, and psychosocial management, the focus needs to shift towards 
recommendations for the specific problems men with prostate cancer face, such as resistance 
exercise to increase loss of muscle mass associated with treatments 76. We propose that the 
guidelines need to be updated to reflect information matched to the particular needs of individual 
men.  
Although there was evidence to support the use of psychosocial interventions involving 
peer support, cognitive-behavioural, psychotherapy, and communication to improve quality of 
life and mental health outcomes, there was less support for simple education or information 
provision interventions. A clear understanding of which components of psychosocial 
interventions are both effective and acceptable for men with prostate cancer is a priority. Trial 
quality in this area could be improved by attention to statistical power, use of consistent outcome 
measures, and by targeting patients at most need 49. In this regard, the application of stepped or 
tiered care models where intervention is matched to the depth of needed, and stepped up when 
required through the use of regular screening and assessment is a needed future direction 77. 
Future research is needed to examine the acceptability and effectiveness of exercise and 
psychosocial interventions in more diverse populations, and strategies to support optimal 
translation into routine clinical practice are needed. In a controlled trial, the benefits of specific 
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exercise regimes compared to usual care can be clearly tested; however, there is limited evidence 
of these interventions being scaled effectively to reach large sections of the population in real-
world settings. For such interventions to be successfully implemented population-wide, this 
relies on strategies for motivating men to engage in self-directed exercise. This may be 
particularly difficult for men who have not previously exercised or who experience physical 
constraints or side effects. An intervention that involved 6 months of supervised exercise 
followed by 6 months of self-directed exercise showed that men were able to preserve 
improvements in cardiorespiratory fitness, physical function, muscle strength and self-reported 
physical functioning that took place within the first 6 months 78, providing a potential strategy to 
overcome the self-motivation issue. Again, for psychosocial interventions which have been 
shown to be effective in a controlled trial environment, further understanding of how these can 
be implemented into practice is required, as limited work has investigated the feasibility of 
scaling to larger populations. Future trials also need to assess how to sustain intervention effects 
over a longer follow-up period. Thus, there is work to be done before translating targeted 
interventions suited to the diverse range of patients who are diagnosed with prostate cancer into 
practice 79. 
Study limitations 
 This synthesis of systematic reviews provides an overview of current evidence on the 
effectiveness of a variety of interventions on health and wellbeing outcomes across the five 
domains of prostate cancer survivorship. By bringing together evidence from extensive 
previously published literature, this synthesis provides insight into the current state of research in 
the area, however, there are some limitations which need to be acknowledged. The reviews of 
interest included a wide variety of intervention types, study designs, and outcomes measures, 
making it challenging to compare and to identify similar themes across different reviews. 
Additionally, the reporting of quality assessments was also lacking in some cases, and many 
included reviews provided a narrative synthesis rather than a meta-analysis, and did not report 
odds ratios or effect sizes due to the heterogeneity of primary studies. The search terms and 
search logic were not overseen by a certified medical librarian, and although a thorough search 
of pertinent databases was conducted by two authors, we also cannot guarantee that some 
relevant reviews may not have been located.  
Clinical implications 
This review highlights the need for contemporary prostate cancer survivorship 
interventions that address all relevant survivorship domains, with an integrated or 
multicomponent approach that builds synergies between approaches. Methods for developing, 
testing and implementing complex interventions are now well described 80, and the application of 
these will help ensure feasibility for implementation at scale is a priority. Men with prostate 
cancer often experience long term decrements in quality of life and psychological wellbeing as a 
result of their cancer experience. Long term survivorship care that is responsive to their specific 
concerns is crucial. 
Conclusions 
The five domains of the ACS Prostate Cancer Survivorship Care Guidelines provide a 
framework for comprehensive follow-up care and optimal health and quality of life for men with 
prostate cancer. Without high quality evidence, solutions to improving outcomes among prostate 
cancer survivors will continue to be obscured to clinicians, researchers and policy-makers. While 
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there is evidence for the effectiveness of exercise and psychosocial interventions for men with 
prostate cancer  in three of the five domains, methods for successfully scaling these interventions 
to large populations are not well described, nor is the optimal approach to tailoring for specific 
needs well understood. In addition, for surveillance and care coordination, review evidence is 
absent and this must serve as a concern for all interested in the welfare of men with prostate 
cancer and their families. Recent advances in prostate cancer treatment and care have led to 
increased survival for men with prostate cancer. Our review highlights the need for survivorship 
interventions to be developed, tested and proven at a similar pace to the rate of progress in anti-
cancer therapies. Priority therefore needs to be given to research that identifies ways to provide 
an effective range of interventions to meet the survivorship needs of men with prostate cancer.  
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Table 1. Narrative synthesis of high-quality reviews published in the last five years 
Domain Health Promotion Surveillance Physical side effects Psychosocial management Care-coordination 
ACS Guidelines Counsel survivors to achieve 
and maintain healthy weight, 
and avoid or limit alcohol and 
tobacco products. 
Measure serum PSA every 6 
to 12 months, and perform 
annual DRE. 
Assess and manage long-term 
treatment related side effects. 
Identify, treat, and manage 
ongoing psychosocial effects. 
Cancer specialists should 
provide all prostate cancer 
patients with a survivorship 
care plan. 
Number of reviews  11 
 
0 16 
 
18 
 
2 
 
Outcomes Physical activity (n=5) 
Body weight and composition 
(n=7) 
PSA (n=2) 
 Cardiorespiratory fitness and 
physical function (n=5)  
Fatigue (n=8) 
Incontinence (n=2) 
QoL (n=12) 
Depression (n=5)  
Anxiety (n=2) 
Self-efficacy (n=2) 
 
Summary of findings Both aerobic and resistance 
exercise demonstrate increases 
in overall physical activity 
levels. Exercise interventions 
were reported to 
preserve/improve lean mass 
with inconsistent effects on 
other parameters of body 
composition. Diet interventions 
were reported to achieve 
significant weight loss. 
Individual nutrition 
interventions also showed some 
small positive impacts on PSA 
levels, particularly plant-based 
supplements, but overall there 
was inconclusive evidence of 
the effectiveness of diet 
interventions on PSA levels. 
 
 Both aerobic and resistance 
exercise demonstrate 
improvements in 
cardiorespiratory fitness, muscle 
strength, and physical function. 
Aerobic training interventions 
showed improvements in peak 
oxygen uptake, while resistance 
training showed improvements 
in muscle strength. Exercise 
interventions were reported to 
have inconsistent effects on 
markers of cardiovascular health 
such as lipid profile, blood 
pressure and glucose. Limited 
information exists on the impact 
of exercise and bone health in 
men with prostate cancer.   
 
Combinations of education, 
cognitive behavioural, peer 
support, and communication 
components within psychosocial 
interventions were found to be the 
most commonly utilized and 
effective. Multi-modal 
psychosocial interventions were 
described as effective for decision-
related distress, mental health, and 
domain-specific and health-related 
quality of life. Psychosocial 
interventions also appear to have 
short-term benefit on depression 
and anxiety, particularly when 
isolating the peer support and 
psychotherapy components. 
Exercise interventions including 
aerobic or resistance training 
predominantly report 
improvements in QoL outcomes, 
particularly supervised aerobic and 
resistance training. Aerobic and 
resistance training exercise 
interventions reported no effect on 
depression or anxiety outcomes. 
 
Reviews relating to care-
coordination outcomes 
were not identified. Limited 
evidence was found for 
psychosocial interventions 
targeting self-efficacy and 
coping, which may serve as 
a proxy in this domain.  
Quality of evidence The bodies of evidence from 
exercise interventions were 
predominantly rated as high 
quality and low risk of bias, 
while nutrition interventions 
were of poorer methodological 
quality. 
 Evidence was predominantly 
rated as high quality with only 
one review of psychosocial 
interventions rating the body of 
evidence as low quality. 
Psychosocial intervention evidence 
was rated as low to moderate in 
most reviews. Exercise 
intervention evidence rated as 
moderate to high quality, and low 
risk of bias. 
No reviews on care 
coordination identified.  
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Figure 1. Methodological quality checklist (adapted from Database of Abstracts of Reviews of Effects) 
1. Is there a well‐defined research question? 
2. Is there a defined search strategy? 
3. Were inclusion/exclusion criteria reported? 
4. Were the included studies synthesized? 
5. Are the primary study designs and number of studies clearly stated? 
6. Was the quality of the included studies assessed? 
7. Has more than one author been involved at each stage of the review process? 
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Figure 2. Flow diagram of included studies 
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